Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

High-Performance Liquid Chromatography: Elution Process01:05

High-Performance Liquid Chromatography: Elution Process

In High-Performance Liquid Chromatography (HPLC), the elution process is critical to the separation of analytes and the quality of chromatographic results. Elution describes how compounds move through the column and separate based on their interactions with the mobile and stationary phases. This process determines the resolution, peak shape, and retention times in the chromatogram, which are essential for identifying and quantifying components in complex mixtures. Understanding the elution...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Left ventricular recovery and outcomes in patients with a durable left ventricular assist device: the EUROMACS registry.

European heart journal·2026
Same author

Near-zero Ischemia After Prolonged Warm Ischemic Time: Beating-heart DCD Heart Transplantation Following Thoracoabdominal Normothermic Regional Perfusion.

Transplantation·2026
Same author

Vanishing Aortic Valve Cusp: A Rare Case of Aortic Valve Insufficiency in a Durable Left Ventricular Assist Device Recipient After Micro-Axial Flow Pump Support.

Artificial organs·2026
Same author

Pressure-Volume-Derived Ventricular Energetics Across Mechanical Circulatory Support Strategies in Cardiogenic Shock.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Huge Descending Aorta Thrombus in ECPELLA to Durable Left Ventricular Assist Device Recipient Treated With Inari FlowTriever: A Case Report.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Baseline PaO2 Modifies the Impact of Oxygenator Use in Temporary Right Ventricular Assist Device Support: A Multicenter Propensity-Weighted Analysis.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026

Related Experiment Video

Updated: May 31, 2026

High Speed Droplet-based Delivery System for Passive Pumping in Microfluidic Devices
10:22

High Speed Droplet-based Delivery System for Passive Pumping in Microfluidic Devices

Published on: September 2, 2009

Levitronix CentriMag third-generation magnetically levitated continuous flow pump as bridge to solution.

Antonio Loforte1, Andrea Montalto, Federico Ranocchi

  • 1Department of Cardiac Surgery and Transplantation, San Camillo Hospital, Rome, Italy. antonioloforte@yahoo.it

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|June 25, 2011
PubMed
Summary
This summary is machine-generated.

The Levitronix CentriMag ventricular assist device (VAD) offers effective temporary extracorporeal support, showing encouraging outcomes for patients ineligible for transplantation. This magnetically levitated pump demonstrated no device failures and facilitated recovery or bridge-to-transplant in over half of the patients.

More Related Videos

Microinjectrode System for Combined Drug Infusion and Electrophysiology
08:30

Microinjectrode System for Combined Drug Infusion and Electrophysiology

Published on: November 13, 2019

Continuous Liquid-Liquid Extraction of Medium-Chain Fatty Acids from Fermentation Broth Using Hollow-Fiber Membranes
06:45

Continuous Liquid-Liquid Extraction of Medium-Chain Fatty Acids from Fermentation Broth Using Hollow-Fiber Membranes

Published on: August 9, 2024

Related Experiment Videos

Last Updated: May 31, 2026

High Speed Droplet-based Delivery System for Passive Pumping in Microfluidic Devices
10:22

High Speed Droplet-based Delivery System for Passive Pumping in Microfluidic Devices

Published on: September 2, 2009

Microinjectrode System for Combined Drug Infusion and Electrophysiology
08:30

Microinjectrode System for Combined Drug Infusion and Electrophysiology

Published on: November 13, 2019

Continuous Liquid-Liquid Extraction of Medium-Chain Fatty Acids from Fermentation Broth Using Hollow-Fiber Membranes
06:45

Continuous Liquid-Liquid Extraction of Medium-Chain Fatty Acids from Fermentation Broth Using Hollow-Fiber Membranes

Published on: August 9, 2024

Area of Science:

  • Cardiovascular Surgery
  • Medical Devices
  • Mechanical Circulatory Support

Background:

  • Temporary extracorporeal support is crucial for critically ill cardiac patients.
  • Magnetically levitated rotary pumps offer advanced VAD technology.
  • Assessing the efficacy of novel VADs in complex patient populations is vital.

Purpose of the Study:

  • To evaluate the clinical outcomes of the Levitronix CentriMag ventricular assist device (VAD).
  • To assess the device's utility in patients unsuitable for traditional transplantation or long-term VADs.
  • To analyze safety and management aspects of the Levitronix CentriMag VAD.

Main Methods:

  • Retrospective analysis of 42 adult patients receiving Levitronix CentriMag support.
  • Patients categorized into postcardiotomy support (Group A) and refractory heart failure (Group B).
  • Data collected on support duration, indications, complications, and patient outcomes.

Main Results:

  • No device failures were reported during the study period.
  • Overall, 52.3% of patients were weaned, recovered, bridged to heart transplantation, or survived.
  • Bleeding requiring reoperation occurred in 35.7% and major cerebral events in 9.5% of patients.

Conclusions:

  • The Levitronix CentriMag VAD is a useful and technically manageable device for temporary circulatory support.
  • Encouraging outcomes were observed, particularly in patients with complex conditions.
  • The device provides a viable option for patients previously deemed unsuitable for other interventions.